Mylan

Source: www.moreover.com --- 26 days ago
Risperidone is a generic form of Risperdal, which is made by New Jersey-based Janssen, a division of Ortho-McNeil-Janssen Pharmaceuticals Inc. Risperdal is used to treat schizophrenia and bipolar disorder. ...

Source: www.marketwatch.com --- 34 days ago
SAN FRANCISCO (MarketWatch) -- Mylan Inc. said late Monday it will retain its specialty drug business Dey LP following a strategic review of the unit. Mylan, however, said it will relocate Dey's commercial operations from Napa, Calif. to the East Coast. Pittsburgh-based Mylan backed its adjusted earnings outlook of 47 cents to 53 cents a share for 2008, 90 cents to $1.10 a share for 2009, and $1.50 to $1.70 a share for 2010. Analysts surveyed by FactSet Research estimate 54 cents a share for 2008, $1.01 for 2009, and $1.42 a share for 2010. ...

Source: www.marketwatch.com --- 4 days ago
BOSTON (MarketWatch) -- Drug stocks advanced in early action Thursday, led by Mylan Laboratories . The Amex Pharmaceutical Index rose marginally to 264.52 and the Amex Biotechnology Index jumped 2% to 681.36. Shares of Mylan climbed almost 4% to $8.01. The generic drugmaker said that it has swapped $500 million of its debt from a floating rate to a more favorable fixed rate. Mylan's chief financial officer, Edward Borkowski, said in a statement that the company also belives that the slide in its stock price was due to "the need for certain institutions to meet capital requirements and by unwarranted concern regarding our capital structure." ...

Source: online.wsj.com --- 34 days ago
Mylan said it will its specialty pharmaceutical subsidiary Dey after a review of strategic alternatives. ...

Source: sanfrancisco.bizjournals.com --- 34 days ago
Generic drug maker Mylan Inc. said it will move commercial operations, R&D, manufacturing and administrative jobs from its 500-employee Dey LP facility in Napa and sell the site. ...

Source: www.post-gazette.com --- 3 days ago
Amid a plunge in its stock price, Mylan Inc. yesterday sought to soothe nervous investors, saying the company was fundamentally strong and ready to face "this difficult credit environment." ...

Source: clientportal.ibb.ubs.com --- 7 days ago
This document is related to the following: Regions Global Americas United States North America Sectors Global Pharmaceuticals Global Healthcare Americas Pharmaceuticals US Pharmaceuticals Americas Healthcare US Healthcare North American Pharmaceuticals North American Healthcare Companies MYL.N Mylan Laboratories Subjects Company Update Morning Note ...

Source: www.moreover.com --- 7 days ago
Kiplinger Oct 5 2008 2:23PM GMT ...

Source: www.moreover.com --- 3 days ago
Pharma Live Oct 9 2008 5:21PM GMT ...

Source: www.cen-chemjobs.org --- 27 days ago
A minimum of a Bachelor's degree in Chemistry or related fiedl is required. 1-2 years of experience is preferred. However, a combination of experience/education will be taken into consideration. Myla ...

Source: www.moreover.com --- 34 days ago
Aastocks.com Sep 9 2008 4:48AM GMT ...

Source: www.moreover.com --- 24 days ago
Citybizlist Sep 18 2008 2:58PM GMT ...

Source: www.pittsburghlive.com --- 3 days ago
It's "well capitalized" and able to manage debt from its purchase of a Merck unit, he says. ...

Source: www.news-medical.net --- 26 days ago
Mylan Inc today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Risperidone Tablets USP, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg. ...

Source: www.streetinsider.com --- 34 days ago
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Mylan+%28MYL%29+Completes+Review+of+Strategic+Alternatives+for+Dey%3B+Reaffirms+FY08%2C+FY09%2C+FY10+Outlook/3972481.html for the full story. ...

Source: www.streetinsider.com --- 27 days ago
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Mylan+%28MYL%29+Receives+Final+Approval+from+FDA+for+Risperidone+Tablets/3992376.html for the full story. ...

Source: www.ad-hoc-news.de --- 17 days ago
New York (aktiencheck.de AG) - Die Analysten von Needham ;amp; Co stufen die Aktie von Mylan (ISIN US6285301072/ WKN 868270) in einer Ersteinschätzung mit strong buy ein. Das Kursziel werde bei 19 USD gesehen. (26.09.2008/ac/a/u) ...

Source: www.streetinsider.com --- 18 days ago
Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/Stanford+Starts+Mylan+%28MYL%29+at+Buy/4016277.html for the full story. ...

Source: www.topix.com --- 31 days ago
Following the completion of a comprehensive review of strategic alternatives for Dey, L.P., Mylan Inc.'s branded specialty pharmaceutical subsidiary, Mylan announced today that it will retain the Dey business. ...

Source: www.topix.com --- 2 days ago
MYL Stock Quote - Mylan Laboratories Inc Stock Quote - MYL Quote - MYL Stock Price Intraday data provided by Interactive Data Real Time Services , a division of Interactive Data Corp. ...